HTFL Heartflow, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1464521 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY47.4%
TTM net income YoY37.0%
TTM EPS YoY106.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin81.8%
Operating margin-33.1%
Net margin-33.1%
FCF margin-23.5%
EBITDA margin-30.8%
Returns
ROE-29.4%
ROA-22.0%
ROIC (approx.)-58.2%
Asset turnover0.66x
Leverage & solvency
Liabilities / assets20.5%
Debt / equity0.00x
Current ratio4.41x
Interest coverage-4,937.50x
Cash quality & payout
Operating cash flow / net income0.62x
Accruals ratio-8.4%
Payout ratio—
Capex / revenue3.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $72.86M | $64.08M | $52.59M | $49.13M | $46.28M | $43.42M | $37.20M | $34.98M |
| Cost of revenue | $11.94M | $10.89M | $10.42M | $10.07M | $10.86M | $10.65M | $9.26M | $8.73M |
| Gross profit | $60.92M | $53.19M | $42.16M | $39.06M | $35.41M | $32.78M | $27.94M | $26.25M |
| R&D expense | $29.49M | $26.26M | $21.62M | $18.66M | $17.30M | $15.03M | $13.92M | $12.28M |
| SG&A expense | $45.28M | $44.83M | $42.57M | $38.15M | $33.22M | $31.46M | $31.52M | $30.03M |
| Operating income | -$13.85M | -$17.90M | -$29.50M | -$17.75M | -$15.10M | -$13.71M | -$17.50M | -$16.06M |
| Interest expense | $5,000 | $0 | $3,000 | $8,000 | $3.45M | $6.62M | $5.09M | $5.15M |
| Pretax income | -$11.48M | -$15.72M | -$27.36M | -$24.56M | -$50.83M | -$9.14M | -$32.34M | -$32.97M |
| Income tax | $23,000 | $22,000 | $23,000 | -$165,000 | $30,000 | $59,000 | — | $5,000 |
| Net income | -$11.51M | -$15.74M | -$27.38M | -$24.39M | -$50.85M | -$9.20M | -$32.34M | -$32.98M |
| EBITDA | -$12.46M | -$16.68M | -$28.08M | -$16.38M | -$13.80M | -$12.32M | -$16.13M | -$14.47M |
| EPS (basic) | -0.13 | -0.18 | -0.32 | — | -1.04 | -1.46 | -5.25 | — |
| EPS (diluted) | -0.13 | -0.18 | -0.32 | — | -1.04 | -1.46 | -5.25 | — |
| Weighted avg. shares (diluted) | 87.25M | 86.40M | 85.64M | — | 49.11M | 6.32M | 6.16M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $31.65M | $34.36M | $19.67M | $44.78M | $291.17M | $80.21M | $109.79M | $55.84M |
| Short-term investments | $136.09M | $128.19M | $138.65M | $132.01M | — | — | — | — |
| Receivables | $48.20M | $42.76M | $35.53M | $29.34M | $27.86M | $29.69M | — | $24.64M |
| Current assets | $235.50M | $223.97M | $211.83M | $220.20M | $327.79M | $118.44M | — | $82.29M |
| PP&E, net | $10.09M | $9.65M | $9.83M | $8.59M | $7.98M | $8.07M | — | $8.92M |
| Total assets | $355.34M | $344.46M | $344.02M | $359.45M | $364.40M | $159.36M | — | $118.70M |
| Current liabilities | $53.41M | $44.09M | $38.02M | $42.37M | $37.85M | $32.94M | — | $33.60M |
| Total liabilities | $72.80M | $64.74M | $58.31M | $58.80M | $109.83M | $285.59M | — | $209.62M |
| Shareholders' equity | $282.54M | $279.73M | $285.72M | $300.65M | $254.57M | -$894.79M | -$889.00M | -$859.48M |
| Shares outstanding | 87.79M | 86.72M | 86.11M | 85.28M | 83.47M | 6.39M | — | 6.12M |
| Cash flow statement | ||||||||
| Operating cash flow | $323,000 | -$8.58M | -$30.10M | -$10.60M | -$2.96M | -$27.30M | -$13.17M | -$14.04M |
| Capital expenditure | $1.40M | $1.92M | $1.89M | $1.90M | $1.24M | $790,000 | $1.10M | $332,000 |
| Free cash flow | -$1.08M | -$10.50M | -$31.99M | -$12.49M | -$4.19M | -$28.09M | -$14.27M | -$14.37M |
| Investing cash flow | -$10.45M | $21.22M | -$1.43M | -$235.44M | -$1.24M | -$790,000 | -$1.10M | -$332,000 |
| Financing cash flow | $7.44M | $2.05M | $6.16M | -$50,000 | $214.94M | -$1.77M | $72.92M | $851,000 |
| Depreciation & amortization | $1.39M | $1.22M | $1.42M | $1.37M | $1.30M | $1.40M | $1.37M | $1.59M |
| Stock-based compensation | $7.57M | $7.91M | $6.55M | $5.26M | $3.96M | $2.25M | $2.49M | $2.51M |
Free plan shows the latest 8 periods; Pro shows all 11 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.